AMIX: Autonomix Medical Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Autonomix Medical Inc (AMIX).
$4.31M Market Cap.
AMIX Market Cap. (MRY)
AMIX Shares Outstanding (MRY)
AMIX Assets (MRY)
Total Assets
$9.81M
Total Liabilities
$1.71M
Total Investments
$0
AMIX Income (MRY)
Revenue
$0
Net Income
-$11.41M
Operating Expense
$11.59M
AMIX Cash Flow (MRY)
CF Operations
-$8.26M
CF Investing
-$14.00K
CF Financing
$8.80M
AMIX Balance Sheet (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total Assets | $9,806,000 (4.24%) | $9,407,000 (987.51%) | $865,000 (-57.86%) | $2,052,747 |
Assets Current | $9,609,000 (2.32%) | $9,391,000 (985.66%) | $865,000 (-57.86%) | $2,052,747 |
Assets Non-Current | $197,000 (1131.25%) | $16,000 (0%) | $0 (0%) | $0 |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Shareholders Equity | $8,099,000 (6.17%) | $7,628,000 (1084.47%) | $644,000 (-67.13%) | $1,959,505 |
Property Plant & Equipment Net | $21,000 (31.25%) | $16,000 (0%) | $0 (0%) | $0 |
Cash & Equivalents | $9,136,000 (6.13%) | $8,608,000 (895.14%) | $865,000 (-57.68%) | $2,044,016 |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Trade & Non-Trade Payables | $676,000 (37.40%) | $492,000 (184.39%) | $173,000 (88.82%) | $91,622 |
Accumulated Retained Earnings (Deficit) | -$50,379,000 (-29.28%) | -$38,969,000 (-65.52%) | -$23,543,000 (-9.23%) | -$21,552,988 |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Total Debt | $0 (0%) | $1,002,000 (0%) | $0 (0%) | $0 |
Debt Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Debt Non-Current | $0 (0%) | $1,002,000 (0%) | $0 (0%) | $0 |
Total Liabilities | $1,707,000 (-4.05%) | $1,779,000 (704.98%) | $221,000 (137.02%) | $93,242 |
Liabilities Current | $1,707,000 (119.69%) | $777,000 (251.58%) | $221,000 (137.02%) | $93,242 |
Liabilities Non-Current | $0 (0%) | $1,002,000 (0%) | $0 (0%) | $0 |
AMIX Income Statement (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Selling General & Administrative Expense | $6,863,000 (30.75%) | $5,249,000 (321.61%) | $1,245,000 (-90.84%) | $13,590,206 |
Research & Development Expense | $4,725,000 (112.36%) | $2,225,000 (198.66%) | $745,000 (18209.17%) | $4,069 |
Operating Expenses | $11,588,000 (-3.67%) | $12,030,000 (504.52%) | $1,990,000 (-85.36%) | $13,594,275 |
Interest Expense | $176,000 (122.78%) | $79,000 (0%) | $0 (0%) | $218,088 |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$11,410,000 (26.03%) | -$15,426,000 (-675.18%) | -$1,990,000 (85.07%) | -$13,328,715 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Income | -$11,410,000 (26.03%) | -$15,426,000 (-675.18%) | -$1,990,000 (85.07%) | -$13,328,715 |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | -$486,887 |
Net Income Common Stock | -$11,410,000 (26.03%) | -$15,426,000 (-675.18%) | -$1,990,000 (84.50%) | -$12,841,828 |
Weighted Average Shares | $1,766,425 (69.73%) | $1,040,720 (73.12%) | $601,156 (480.20%) | $103,612 |
Weighted Average Shares Diluted | $1,766,425 (69.73%) | $1,040,720 (73.12%) | $601,156 (480.20%) | $103,612 |
Earning Before Interest & Taxes (EBIT) | -$11,234,000 (26.80%) | -$15,347,000 (-671.21%) | -$1,990,000 (84.82%) | -$13,110,627 |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Operating Income | -$11,588,000 (3.67%) | -$12,030,000 (-504.52%) | -$1,990,000 (85.36%) | -$13,594,275 |
AMIX Cash Flow Statement (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$14,000 (26.32%) | -$19,000 (0%) | $0 (0%) | $0 |
Net Cash Flow from Financing | $8,800,000 (-38.93%) | $14,410,000 (2034.81%) | $675,000 (-72.22%) | $2,430,186 |
Net Cash Flow from Operations | -$8,258,000 (-24.22%) | -$6,648,000 (-258.58%) | -$1,854,000 (-378.69%) | -$387,307 |
Net Cash Flow / Change in Cash & Cash Equivalents | $528,000 (-93.18%) | $7,743,000 (756.74%) | -$1,179,000 (-157.71%) | $2,042,879 |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Capital Expenditure | -$14,000 (26.32%) | -$19,000 (0%) | $0 (0%) | $0 |
Issuance (Repayment) of Debt Securities | $0 (0%) | $2,000,000 (0%) | $0 (0%) | $536,000 |
Issuance (Purchase) of Equity Shares | $10,028,000 (-26.83%) | $13,706,000 (1930.52%) | $675,000 (-66.33%) | $2,004,664 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Share Based Compensation | $1,628,000 (163.43%) | $618,000 (0%) | $0 (0%) | $13,166,832 |
Depreciation Amortization & Accretion | $183,000 (125.93%) | $81,000 (0%) | $0 (0%) | $0 |
AMIX Financial Metrics (MRY)
Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -174.70% (53.16%) | -373.00% (-143.95%) | -152.90% | - |
Return on Average Assets (ROAA) | -133.40% (55.59%) | -300.40% (-120.23%) | -136.40% | - |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 3323.70% (186.95%) | -3822.40% (-393.42%) | 1302.70% | - |
Dividend Yield | 0% (0%) | 0% | - | - |
Price to Earnings Ratio (P/E) | -0.27 (93.35%) | -4.08 | - | - |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 0.53 (-92.85%) | 7.44 | - | - |
Debt to Equity Ratio (D/E) | 0.21 (-9.44%) | 0.23 (-32.07%) | 0.34 (614.58%) | 0.05 |
Earnings Per Share (EPS) | -6.46 (56.41%) | -14.82 (-335.88%) | -3.4 (97.26%) | -124 |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 |
Free Cash Flow Per Share (FCFPS) | -4.68 (26.90%) | -6.41 (-107.72%) | -3.08 (17.50%) | -3.74 |
Book Value Per Share (BVPS) | 4.58 (-37.45%) | 7.33 (584.41%) | 1.07 (-94.34%) | 18.91 |
Tangible Assets Book Value Per Share (TABVPS) | 5.55 (-38.59%) | 9.04 (528.14%) | 1.44 (-92.74%) | 19.81 |
Enterprise Value Over EBIT (EV/EBIT) | 1 (125.00%) | -4 | - | - |
Enterprise Value Over EBITDA (EV/EBITDA) | 0.58 (115.45%) | -3.73 | - | - |
Asset Turnover | 0 (0%) | 0 (0%) | 0 | - |
Current Ratio | 5.63 (-53.43%) | 12.09 (208.79%) | 3.91 (-82.22%) | 22.02 |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$8,272,000 (-24.07%) | -$6,667,000 (-259.60%) | -$1,854,000 (-378.69%) | -$387,307 |
Enterprise Value (EV) | -$6,380,780 (-111.19%) | $56,996,801 | - | - |
Earnings Before Tax (EBT) | -$11,410,000 (26.03%) | -$15,426,000 (-675.18%) | -$1,990,000 (85.07%) | -$13,328,715 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$11,051,000 (27.61%) | -$15,266,000 (-667.14%) | -$1,990,000 (84.82%) | -$13,110,627 |
Invested Capital | -$1,037,000 (-201.27%) | $1,024,000 (563.35%) | -$221,000 (-161.50%) | -$84,511 |
Working Capital | $7,902,000 (-8.27%) | $8,614,000 (1237.58%) | $644,000 (-67.13%) | $1,959,505 |
Tangible Asset Value | $9,806,000 (4.24%) | $9,407,000 (987.51%) | $865,000 (-57.86%) | $2,052,747 |
Market Capitalization | $4,310,220 (-92.41%) | $56,757,801 | - | - |
Average Equity | $6,530,750 (57.90%) | $4,136,000 (217.73%) | $1,301,752 | - |
Average Assets | $8,556,000 (66.59%) | $5,136,000 (252.05%) | $1,458,874 | - |
Invested Capital Average | -$338,000 (-184.18%) | $401,500 (362.84%) | -$152,756 | - |
Shares | 2,462,983 (162.10%) | 939,699 (52.34%) | 616,829 | - |
